Physician profile
Kenna Larsen
NPI 1073723375
$1,658.85
in general payments reported to CMS, 2019-2025
38 companies · $329 in 2025
The $329 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $458 · 2020: $103 · 2021: $48.05 · 2022: $215 · 2023: $330 · 2024: $177 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $835.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $172.49 | 2019-2023 | Xiaflex |
| Pacira Pharmaceuticals Incorporated | $171.64 | 2023-2024 | Iovera, Zilretta, Exparel |
| Radius Health, INC. | $152.02 | 2019-2020 | |
| Anika Therapeutics, INC. | $126.80 | 2022-2025 | Wristmotion, X-Twist, Total Anika |
| Stryker Corporation | $113.10 | 2022-2025 | Gamma |
| Orthofix Medical, INC. | $73.63 | 2023-2025 | Physio-Stim |
| Zimmer Biomet Holdings, INC. | $61.25 | 2025 | Persona |
| Bioventus LLC | $54.52 | 2019-2024 | Durolane, Durolane |
| Sanofi-Aventis U.S. LLC | $50.66 | 2019-2024 | |
| Smith+Nephew, INC. | $45.88 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $41.98 | 2025 | |
| Amgen INC. | $41.65 | 2019 | |
| Acell, INC. | $38.62 | 2019 | |
| Solventum Corporation | $33.52 | 2025 | Prevena |
| Depuy Synthes Sales INC. | $32.03 | 2024-2025 | Orthovisc, Monovisc, Fms |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenna Larsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.